NYSEAMERICAN:SENS - Senseonics Stock Price, Forecast & News

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics Holdings Inc (NYSEAMERICAN:SENS) issued its quarterly earnings data on Wednesday, August, 8th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.09. The business earned $3.62 million during the quarter, compared to analysts' expectations of $3.87 million. The business's revenue was up 345.1% on a year-over-year basis. During the same period last year, the firm posted ($0.12) EPS. View Senseonics' Earnings History.

Senseonics is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Senseonics.

Senseonics updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$20-22 million, compared to the consensus revenue estimate of $$26.62 million.

6 Wall Street analysts have issued 12-month price targets for Senseonics' shares. Their forecasts range from $1.00 to $2.50. On average, they expect Senseonics' stock price to reach $1.90 in the next year. This suggests a possible upside of 29.3% from the stock's current price. View Analyst Price Targets for Senseonics.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Senseonics.

News stories about SENS stock have been trending somewhat negative on Wednesday, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Senseonics earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Senseonics.

Senseonics saw a decrease in short interest during the month of January. As of January 31st, there was short interest totalling 35,100,000 shares, a decrease of 9.1% from the January 15th total of 38,630,000 shares. Based on an average daily trading volume, of 1,480,000 shares, the days-to-cover ratio is presently 23.7 days. Approximately 31.2% of the company's stock are short sold. View Senseonics' Current Options Chain.

Some companies that are related to Senseonics include Integral Diagnostics (IDX), Volpara Health Tech (VHT), Profound Medical (PRN), Akumin (AKU), Exagen (XGN), Renalytix Ai (RENX), Palatin Technologies (PTN), Oncosil Medical (OSL), Yourgene Health (YGEN), MaxCyte (MXCT), Lexagene (LXG), BARD1 Life Sciences (BD1), Oncimmune (ONC), Sernova (SVA) and GeneNews (GEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include Agile Therapeutics (AGRX), Tandem Diabetes Care (TNDM), VirnetX (VHC), Advanced Micro Devices (AMD), Melinta Therapeutics (MLNT), Micron Technology (MU), Nabriva Therapeutics (NBRV), Aduro BioTech (ADRO), Sorrento Therapeutics (SRNE) and vTv Therapeutics (VTVT).

Senseonics' stock is owned by a number of of institutional and retail investors. Top institutional investors include Delphi Management Partners VIII L.L.C. (4.84%), Silverback Asset Management LLC (1.34%), State Street Corp (0.91%), Raymond James & Associates (0.52%), Raymond James Financial Services Advisors Inc. (0.30%) and Daiwa Securities Group Inc. (0.29%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View Institutional Ownership Trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, UBS Group AG, Bank of America Corp DE, Raymond James & Associates, Bank of New York Mellon Corp, Daiwa Securities Group Inc. and Raymond James Financial Services Advisors Inc.. View Insider Buying and Selling for Senseonics.

SENS stock was acquired by a variety of institutional investors in the last quarter, including Delphi Management Partners VIII L.L.C., Virtu Financial LLC, Magnus Financial Group LLC, Spark Investment Management LLC, Palisade Capital Management LLC NJ, Trust Co. of Oklahoma, Goldman Sachs Group Inc. and Barclays PLC. View Insider Buying and Selling for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $1.47.

Senseonics has a market capitalization of $299.08 million. Senseonics employs 192 workers across the globe.View Additional Information About Senseonics.

The official website for Senseonics is http://www.senseonics.com/.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.